An international study has revealed that super-Earth exoplanets, planets larger than Earth but smaller than gas giants like Neptune, are significantly more common across the universe than scientists once believed.
Dr Sylvie Briand, Director, Global Infectious Hazards Preparedness Department at the World Health Organization, explains how COVID-19 is accompanied by fighting an infodemic.
Professor Martin Freer, Director of Birmingham Energy Institute, University of Birmingham, details his thoughts on overcoming our largest challenge to achieve net-zero by 2050.
Rob Solly, Division Head, Defence and Security Analysis, tells us how the Defence Science and Technology Laboratory (Dstl) signals a bright future for SME research in defence and security.
Sue Bateman, Deputy Director for Data and Innovation at the Government Digital Service (GDS), explores data use in government and in this vein, where we’re going next.
Joanne Sweeney, Chief Executive Officer of Public Sector Marketing Institute, shares the top three social media trends for 2021 that relate to government and public sector specifically.
Here, we look into the many ways in which medical and safety technology manufacturer Dräger has been stepping up to help its customers through the COVID-19 crisis.
Open Access Government discovers how Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, is prioritising the recovery of Europe’s cultural sectors as well as Research and Innovation.
Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.
Sylvie Gallage-Alwis, Partner at Signature Litigation, argues here that companies should monitor the European Commission’s environment-related actions.
Michelle Vickers, CEO of the Head and Neck Cancer Foundation tells us what we need to know about head and neck cancer treatment, including comment on driving surgical-technological development.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.
Kathryn Barnes, European Counsel, Globalization Partners, argues that as remote work becomes the norm, it is now essential to hire, onboard, and build trusted teams – virtually.
